نتایج جستجو برای: chemotherapeutic property

تعداد نتایج: 175052  

2013
Ronald T. Raines R. T. Raines

2012
Haoran Li Burton B Yang

Tumor development not only destroys the homeostasis of local tissues but also the whole body, and thus the tumor cells have to face the body's defense system, a shortage of nutrition and oxygen, and chemotherapeutic drug treatment. In response to these stresses, tumor cells often alter gene expression and microRNA levels to facilitate survival. We have demonstrated that glioblastoma cells depri...

2017
Dong Ren Bihua Lin Xin Zhang Yao Peng Ziyu Ye Yan Ma Yangfang Liang Longbin Cao Xiangyong Li Ronggang Li Lixia Sun Qiongru Liu Jinhua Wu Keyuan Zhou Jincheng Zeng

Emerging studies indicated that cancer stem cells represent a subpopulation of cells within the tumor that is responsible for chemotherapeutic resistance. However, the underlying mechanism is still not clarified yet. Here we report that miR-196b-5p is dramatically upregulated in CRC tissues and high expression of miR-196b-5p correlates with poor survival in CRC patients. Moreover, recurrent gai...

2016
Joanna Kopecka Gregory M. Rankin Iris C. Salaroglio Sally-Ann Poulsen Chiara Riganti

Carbonic anhydrase XII (CAXII) is a membrane enzyme that maintains pH homeostasis and sustains optimum P-glycoprotein (Pgp) efflux activity in cancer cells. Here, we investigated a panel of eight CAXII inhibitors (compounds 1-8), for their potential to reverse Pgp mediated tumor cell chemoresistance. Inhibitors (5 nM) were screened in human and murine cancer cells (colon, lung, breast, bone) wi...

Journal: :Journal of cancer research and therapeutics 2009
Fanjie Zhang Rebecca L Aft

BACKGROUND Accelerated glucose uptake for anaerobic glycolysis is one of the major metabolic changes found in malignant cells. This property has been exploited for imaging malignancies and as a possible anticancer therapy. The nonmetabolizable glucose analog 2-deoxyglucose (2 DG) interferes with glucose metabolism leading to breast cancer cell death. AIMS To determine whether 2DG can synergiz...

Journal: :ACS nano 2013
Khuloud T Al-Jamal Wafa' T Al-Jamal Julie T-W Wang Noelia Rubio Joanna Buddle David Gathercole Mire Zloh Kostas Kostarelos

We report in this study the complexation of the chemotherapeutic drug doxorubicin (DOX) with the novel sixth-generation cationic poly-l-lysine dendrimer (DM) (MW 8149 kDa), which we previously reported to exhibit systemic antiangiogenic activity in tumor-bearing mice. DOX-DM complexation was confirmed by florescence polarization measurement, proton nuclear magnetic resonance spectroscopy, and m...

2013
Henry E. Smith HENRY E. SMITH

Ameneh Sarraf Zuhair Mohammad Hassan

Over the past decade, it was widely accepted that some chemotherapeutic drugs can be combined with immunotherapeutic drugs in treatment of cancer. Chemotherapeutic drugs can induce apoptosis in the tumor cell and at the same time stimulate the immune response. Several reports support the use   immunomodulators in treatment of cancers through regulating the immune response and boosting the micro...

Journal: :iranian journal of pharmaceutical research 0
a emami-forushani s zeinali sn ostad

breast cancer is one of the most common malignancies among women. although chemotherapy remains a major therapeutic approach to treat cancers, drug therapy often fails for several reasons, particularly the drug resistance. resistance to multiple chemotherapeutic agents is one of the most important problems in the treatment of different types of cancers. therefore, in this study a resistant sub ...

Journal: :Journal of clinical images and medical case reports 2023

Bortezomib is a chemotherapeutic drug used in the treatment of multiple myeloma and amyloidosis. The major dose limiting adverse effect neuropathy.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید